HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Klaus Scheffler Selected Research
Klaus Scheffler Research Topics
Disease
6
Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2019
5
Neoplasms (Cancer)
02/2022 - 06/2016
5
Cognitive Dysfunction
01/2022 - 01/2020
4
Dementia (Dementias)
01/2022 - 01/2021
4
Atrophy
10/2021 - 01/2019
4
Insulin Resistance
01/2020 - 01/2013
3
Inflammation (Inflammations)
01/2022 - 12/2020
3
Overweight
01/2017 - 06/2015
2
Glioma (Gliomas)
02/2022 - 10/2016
2
Necrosis
02/2022 - 01/2019
2
Phenylketonurias (Phenylketonuria)
01/2021 - 01/2019
2
Brain Neoplasms (Brain Tumor)
01/2019 - 10/2018
2
Obesity
01/2017 - 06/2015
2
Weight Loss (Weight Reduction)
01/2017 - 01/2017
2
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
02/2012 - 11/2009
2
Hyperemia
11/2009 - 11/2006
2
Ischemia
11/2009 - 11/2006
1
Neuroinflammatory Diseases
01/2022
1
Body Weight (Weight, Body)
01/2021
1
Parkinson Disease (Parkinson's Disease)
01/2021
1
Pathologic Processes
01/2020
1
Amyloid Plaque
01/2020
1
Glioblastoma (Glioblastoma Multiforme)
11/2019
1
Prodromal Symptoms
01/2019
1
Hyperphagia (Overeating)
06/2015
1
Type 2 Diabetes Mellitus (MODY)
06/2015
1
Neurodegenerative Diseases (Neurodegenerative Disease)
06/2015
1
Heroin Dependence (Heroin Abuse)
05/2015
1
Nervous System Diseases (Neurological Disorders)
11/2013
1
Sleep Initiation and Maintenance Disorders (Insomnia)
01/2013
1
Non-alcoholic Fatty Liver Disease
01/2013
1
Psychotic Disorders (Schizoaffective Disorder)
10/2012
1
Congenital Abnormalities (Deformity)
08/2012
1
Epilepsy (Aura)
02/2012
1
Myocardial Infarction
09/2009
1
Stress Fractures (Stress Fracture)
10/2008
1
Peripheral Arterial Occlusive Disease 1
11/2006
1
Hypertension (High Blood Pressure)
06/2006
1
Pathologic Constriction (Stenosis)
02/2006
1
Multiple Sclerosis
04/2005
1
Glomus Tumor (Glomus Tumors)
07/2003
Drug/Important Bio-Agent (IBA)
8
Biomarkers (Surrogate Marker)
IBA
01/2022 - 10/2012
7
Amyloid (Amyloid Fibrils)
IBA
01/2022 - 01/2019
5
Glucose (Dextrose)
FDA Link
Generic
02/2022 - 01/2013
3
Protons (Proton)
IBA
10/2021 - 06/2016
3
Amides
IBA
10/2021 - 10/2018
3
Insulin (Novolin)
FDA Link
01/2020 - 06/2015
2
Apolipoproteins E (ApoE)
IBA
01/2022 - 01/2022
2
Cholinergic Agents (Cholinergics)
IBA
01/2022 - 01/2020
2
Phenylalanine (L-Phenylalanine)
FDA Link
01/2021 - 01/2019
2
Oxygen (Dioxygen)
IBA
01/2021 - 11/2006
2
Methylphenidate (Ritalin)
FDA Link
Generic
02/2012 - 11/2009
2
thiamine triphosphorate (TTP)
IBA
11/2009 - 11/2006
2
Contrast Media
IBA
09/2009 - 07/2003
1
Gadolinium
IBA
02/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
Proteins (Proteins, Gene)
FDA Link
01/2022
1
Apoferritins
IBA
01/2022
1
C-Peptide
IBA
01/2020
1
Nasal Sprays
IBA
01/2020
1
Mixed Function Oxygenases (Monooxygenases)
IBA
01/2019
1
Tyrosine (L-Tyrosine)
FDA Link
01/2019
1
Tryptophan (L-Tryptophan)
FDA Link
01/2019
1
Biogenic Amines (Biogenic Amine)
IBA
01/2019
1
Dopamine (Intropin)
FDA Link
Generic
01/2019
1
5-Hydroxytryptophan (5 Hydroxytryptophan)
IBA
01/2019
1
Amino Acids
FDA Link
01/2019
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2019
1
Hydroxyindoleacetic Acid
IBA
01/2019
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
10/2016
1
alpha-hydroxyglutarate
IBA
10/2016
1
Phosphates (Orthophosphate)
IBA
10/2016
1
Glutathione (Reduced Glutathione)
IBA
10/2016
1
NAD (NADH)
IBA
10/2016
1
NADP (NADPH)
IBA
10/2016
1
Phosphorus (Red Phosphorus)
IBA
06/2016
1
Heroin (Diamorphine)
IBA
05/2015
1
Lipids
IBA
01/2013
1
Hydrocortisone (Cortisol)
FDA Link
Generic
01/2013
1
Hormones (Hormone)
IBA
01/2013
1
Polytetrafluoroethylene (Teflon)
FDA Link
10/2012
1
Angiotensin II
IBA
06/2006
1
Gadolinium DTPA (Magnevist)
FDA Link
04/2005
Therapy/Procedure
2
Neurofeedback
01/2017 - 11/2013
1
Mediterranean Diet
05/2021
1
Activities of Daily Living (ADL)
01/2021
1
Spinal Fusion (Spondylosyndesis)
08/2012
1
Transplantation
10/2008
1
Lasers (Laser)
11/2006
1
Catheters
02/2006
1
Intravenous Administration
07/2003